Rituximab for humoral rejection after kidney transplantation: An update

Transplantation

Volumn 87, Issue 8, 2009, Pages 1261-

  Rostaing, Lionel ^a,b   Guilbeau Frugier, Céline ^c   Kamar, Nassim ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; FEMALE; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; ANTIBODY PRODUCTION; B LYMPHOCYTE; DRUG EFFECT; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; MULTIMODALITY CANCER THERAPY; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; B-LYMPHOCYTES; COMBINED MODALITY THERAPY; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; T-LYMPHOCYTES;

EID: 65549163158     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819f627a     Document Type: Letter

References (6)

1. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033.
2. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
3. Pascual M, Saidman S, Tolkoff-Rubin N, et al. Plasmaexchangeandtacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998; 66: 1460.
4. Jordan SC, Vo AA, Tyan D, et al. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 2005; 9: 408.
5. Becker YT, Becker BN, Pirsch JD, et al. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 2004; 4: 996.
6. Faguer S, Kamar N, Guilbeaud-Frugier C, et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007; 83: 1277.